Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases

Author:

Timbie Justin W1ORCID,Kim Alice Y2,Baker Lawrence3ORCID,Li Rosemary4,W Concannon Thomas3ORCID

Affiliation:

1. RAND, Arlington, VA 22202, USA

2. RAND, Santa Monica, CA 90401, USA

3. RAND, Boston, MA 02116, USA

4. RAND, Pittsburgh, PA 15213, USA

Abstract

Aim: Although the US FDA encourages manufacturers of medical devices to submit real-world evidence (RWE) to support regulatory decisions, the ability of real-world data (RWD) to generate evidence suitable for decision making remains unclear. The 2017 Medical Device User Fee Amendments (MDUFA IV), authorized the National Evaluation System for health Technology Coordinating Center (NESTcc) to conduct pilot projects, or ‘Test-Cases’, to assess whether current RWD captures the information needed to answer research questions proposed by industry stakeholders. We synthesized key lessons about the challenges conducting research with RWD and the strategies used by research teams to enhance their ability to generate evidence from RWD based on 18 Test-Cases conducted between 2020 and 2022. Materials & methods: We reviewed study protocols and reports from each Test-Case team and conducted 49 semi-structured interviews with representatives of participating organizations. Interview transcripts were coded and thematically analyzed. Results: Challenges that stakeholders encountered in working with RWD included the lack of unique device identifiers, capturing key data elements and their appropriate meaning in structured data, limited reliability of diagnosis and procedure codes in structured data, extracting information from unstructured electronic health record (EHR) data, limited capture of long-term study end points, missing data and data sharing. Successful strategies included using manufacturer and supply chain data, leveraging clinical registries and registry reporting processes to collect and aggregate data, querying standardized EHR data, implementing natural language processing algorithms and using multidisciplinary research teams. Conclusion: The Test-Cases identified numerous challenges working with RWD but also opportunities to address these challenges and improve researchers' ability to use RWD to generate evidence on medical devices.

Publisher

Becaris Publishing Limited

Reference36 articles.

1. U.S. Food & Drug Administration. Real-World Evidence (2023). https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence

2. European Medicines Agency. Real-world evidence provided by EMA: support for regulatory decision-making (2024). https://www.ema.europa.eu/en/documents/other/guidance-real-world-evidence-provided-ema-support-regulatory-decision-making_en.pdf

3. RM Califf. Realizing the Promise of Real-World Evidence (2023). https://www.fda.gov/news-events/fda-voices/realizing-promise-real-world-evidence

4. Johnson & Johnson. What is real-world evidence and how does it help patients? A Q&A with Josh Gagne Vice President and Global Head of Epidemiology Johnson & Johnson (2022). https://www.jnj.com/office-of-chief-medical-officer/what-is-real-world-evidence-and-how-does-it-help-patients

5. Center for Devices and Radiological Health Administration CfBEaRUSFD. Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices: Guidance for Industry and Food and Drug Administration Staff (2017). https://www.fda.gov/media/99447/download

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3